Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
NOVO.B.DK | Novo Nordisk A/S Class B | 73.9 | ¤579,106 | DK |
RO.CH | Roche Holding Ltd | 60.9 | ¤210,316 | CH |
SYK | Stryker Corporation | 62.7 | ¤133,484 | US |
VRTX | Vertex Pharmaceuticals Incorporated | 62.8 | ¤107,464 | US |
BMY | Bristol-Myers Squibb Company | 61.5 | ¤105,659 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
AMLX | Amylyx Pharmaceuticals, Inc. | 71.3 | ¤183 | US |
OSUR | OraSure Technologies, Inc. | 62.6 | ¤459 | US |
9229.JP | SUNWELS Co.,Ltd. | 70.3 | ¤529 | JP |
IRMD | IRadimed Corp. | 70.1 | ¤544 | US |
001060.KR | JW Pharmaceutical Corporation | 62.6 | ¤596 | KR |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
NOVO.B.DK | Novo Nordisk A/S Class B | 73.9 | 31 | DK |
RMD | ResMed Inc. | 64.3 | 22 | US |
867.HK | China Medical System Holdings Ltd. | 69.3 | 21 | CN |
6869.JP | Sysmex Corporation | 60.7 | 19 | JP |
SYK | Stryker Corporation | 62.7 | 19 | US |
IDXX | IDEXX Laboratories, Inc. | 63.5 | 18 | US |
SOON.CH | Sonova Holding AG | 58.5 | 18 | CH |
BMY | Bristol-Myers Squibb Company | 61.5 | 17 | US |
UTHR | United Therapeutics Corporation | 79.3 | 17 | US |
4519.JP | Chugai Pharmaceutical Co., Ltd. | 58.6 | 16 | JP |
Average Market Cap | ¤18,492 |
Median Market Cap | ¤2,553 |
Avg. 3 Mo. Dollar Vol. | ¤55,520,793 |
Avg. 3 Mo. Trading Vol. | 1,664,575 |
Last Rebalance Date | 03/18/2024 |
Companies Replaced | |
Biggest Industry Increase | Hospital/Nursing Management |
Biggest Industry Decrease | Hospital/Nursing Management |
Trailing P/E Ratio (12 Mo.) | 21.7 |
Forward P/E Ratio (12 Mo.) | 21.7 |
Price/Book Ratio | 4.5 |
Avg. Revenue Chg. - 3 Yr | 65.2% |
Avg. Op. Income Chg. - 3 Yr. | 121.7% |
Avg. EPS Growth - 3 Yr. | 32.3% |
Avg. EPS Growth - 1 Yr. | 18.6% |
Avg. Operating Margin | 22.4% |
Avg. LT Debt to Total Capital | 11.3% |
Avg. Return on Equity | 22.9% |
Dividend Yield | 0.6% |
MarketGrader Global Health Care Leaders Index | 67.86 |